- Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary
- DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors (Running title: Genitourinary infections with the DPP4i/SGLT2i combination)
- Efficacy and Safety of Dual Acetylsalicylic Acid Plus Ticagrelor or Ticagrelor Alone Antiplatelet Strategy After Coronary Artery Bypass Surgery at 12 Months: Randomized Multicentre Trial
- Treatment of Cholesterol in 2017
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes – A Randomized Clinical Trial
- SGLT2 inhibitors in type 1 diabetes: knocked down, but up again?
- Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes
- Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control
- CV HEALTH AND HF IN T2D PATIENTS: OVERCOMING DATA OVERLOAD
- CLINICAL CARE CROSSROADS: NAVIGATING THE INTERSECTION OF HEART FAILURE AND DIABETES
- Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
- Optimal Medical Therapy for Known Coronary Artery Disease – A Review
- A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure. Proposal of a Novel Mechanism of Action
- End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State
Email: info@empakan.gr